The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Some Speculations about Prions, Amyloid, and Alzheimer's Disease
Abstract
The causes of most degenerative diseases are unknown; however, the causes of three degenerative disorders of the central nervous system have been defined by their transmissibility to animals. These diseases are kuru, Creutzfeldt–Jakob disease, and the Gerstmann-Straüssler syndrome.1 , 2 The slow infectious agents that cause these diseases appear to be different from viruses but similar to the agent that causes scrapie, a neurologic disorder of sheep and goats.1 , 3 The term "prion" has been introduced to denote this slow infectious agent, with its unusual properties.3 Studies of the molecular structure of scrapie prions in highly purified preparations indicate that they contain one . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pathologic similarities with prion disease suggest that the formation and spread of these proteinaceous lesions might involve a common molecular mechanism – corruptive protein templating.”
From Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders (2011) · cites this paper as [2]
Citations
Cites
Novel Proteinaceous Infectious Particles Cause Scrapie
Prusiner, S. B. (1982) · Science · doi:10.1126/science.6801762 · Cited by 5,221
Self-citationAlzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,055
Amyloid Deposits and Amyloidosis
Glenner, G. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006053022305 · Cited by 1,780
Scrapie prions aggregate to form amyloid-like birefringent rods
Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D., & Glenner, G. G. (1983) · Cell · doi:10.1016/0092-8674(83)90168-x · Cited by 1,052
Self-citationA protease-resistant protein is a structural component of the Scrapie prion
McKinley, M. P., Bolton, D. C., & Prusiner, S. B. (1983) · Cell · doi:10.1016/0092-8674(83)90207-6 · Cited by 925
Self-citationUnconventional Viruses and the Origin and Disappearance of Kuru
Gajdusek, D. C. (1977) · Science · doi:10.1126/science.142303 · Cited by 671
CREUTZFELDT-JAKOB DISEASE VIRUS ISOLATIONS FROM THE GERSTMANN-STRÄUSSLER SYNDROME
Masters, C. L., Gajdusek, D. C., & Gibbs, C. J. (1981) · Brain · doi:10.1093/brain/104.3.559 · Cited by 527
Abnormal fibrils from scrapie-infected brain
MERZ, P. A., Somerville, R. A., Wı́sniewski, H. M., & Iqbal, K. (1981) · Acta Neuropathologica · doi:10.1007/bf00691333 · Cited by 468
Further purification and characterization of scrapie prions
Prusiner, S. B., Bolton, D. C., Groth, D., Bowman, K. A., Cochran, S. P., & McKinley, M. P. (1982) · Biochemistry · doi:10.1021/bi00269a050 · Cited by 463
Self-citationScrapie infectivity, fibrils and low molecular weight protein
Diringer, H., Gelderblom, H., Hilmert, H., Özel, M., Edelbluth, C., & Kimberlin, R. H. (1983) · Nature · doi:10.1038/306476a0 · Cited by 340
Research works printed but not linked: 1
- Beck E, Daniel FM. Kuru and Creutzfeldt-Jakob disease; neuropathological lesions and their significance. In: Prusiner SB, Hadlow WJ. eds. Slow transmissible diseases of the nervous system. Vol. 1. New York: Academic Press, 1979:253–70.
Cited by
Sorted by citations
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
The hubs of the human connectome are generally implicated in the anatomy of brain disorders
Crossley, N. A., Mechelli, A., Scott, J., Carletti, F., Fox, P. T., McGuire, P., & Bullmore, E. T. (2014) · Brain · doi:10.1093/brain/awu132 · Cited by 1,166
Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies
Sanders, D. W., Kaufman, S. K., DeVos, S. L., Sharma, A. M., Mirbaha, H., Li, A., Barker, S. J., Foley, A. C., Thorpe, J. R., Serpell, L. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.047 · Cited by 986
Proteopathic tau seeding predicts tauopathy in vivo
Holmes, B. B., Furman, J. L., Mahan, T. E., Yamasaki, T. R., Mirbaha, H., Eades, W. C., Belaygorod, L., Cairns, N. J., Holtzman, D. M., & Diamond, M. I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411649111 · Cited by 696
Neurodegenerative Diseases and Prions
Prusiner, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442006 · Cited by 783
Self-citationPredicting Regional Neurodegeneration from the Healthy Brain Functional Connectome
Zhou, J., Gennatas, E. D., Kramer, J. H., Miller, B. L., & Seeley, W. W. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.004 · Cited by 706
The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease
King, O. D., Gitler, A. D., & Shorter, J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.016 · Cited by 654
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders
Jucker, M., & Walker, L. C. (2011) · Annals of Neurology · doi:10.1002/ana.22615 · Cited by 622
“Several lines of evidence49-52 collectively argue that aggregated Aβ in the brain extract is critical for in vivo seeding: (1) The extract is able to seed only if it contains aggregated, human-sequence Aβ; (2) Immunoneutralization/depletion of Aβ in the extract by anti-Aβ antibodies impedes seeding; (3) Seeding of Aβ…”
BackgroundPurification and structural studies of a major scrapie prion protein
Prusiner, S. B., Groth, D., Bolton, D. C., Kent, S. B. H., & Hood, L. (1984) · Cell · doi:10.1016/0092-8674(84)90533-6 · Cited by 494
Self-citationA Unifying Role for Prions in Neurodegenerative Diseases
Prusiner, S. B. (2012) · Science · doi:10.1126/science.1222951 · Cited by 507
Self-citationPrionsPreprint
Colby, D. W., & Prusiner, S. B. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006833 · Cited by 492
Self-citationBiology and Genetics of Prions Causing Neurodegeneration
Prusiner, S. B. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155524 · Cited by 455
Self-citationIsolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease
Selkoe, D. J., Abraham, C. R., Podlisny, M. B., & Duffy, L. K. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb08501.x · Cited by 452
A kinetic model for amyloid formation in the prion diseases: importance of seeding.
Come, J. H., Fraser, P. E., & Lansbury, P. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.5959 · Cited by 395
Neurodegenerative Diseases: Expanding the Prion Concept
Walker, L. C., & Jucker, M. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033828 · Cited by 361
Glutamate dysfunction in Alzheimer's disease: an hypothesis
Maragos, W. F., Greenamyre, J. T., Penney, J. B., & Young, A. B. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90025-7 · Cited by 336
Propagation of Protein Aggregation in Neurodegenerative Diseases
Vaquer‐Alicea, J., & Diamond, M. I. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045049 · Cited by 316
Identification of prion amyloid filaments in scrapie-infected brain
DeArmond, S. J., McKinley, M. P., Barry, R. A., Braunfeld, M. B., McColloch, J. R., & Prusinert, S. B. (1985) · Cell · doi:10.1016/0092-8674(85)90076-5 · Cited by 294
The amyloid cascade hypothesis: an updated critical review
Kepp, K. P., Robakis, N. K. R. K., Høilund‐Carlsen, P. F., Sensi, S. L., & Vissel, B. (2023) · Brain · doi:10.1093/brain/awad159 · Cited by 320
Creasey, H. M., & Rapoport, S. I. (1985) · Annals of Neurology · doi:10.1002/ana.410170103 · Cited by 250
Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy
Cope, T., Rittman, T., Borchert, R. J., Jones, P. S., Vatansever, D., Allinson, K. S. J., Passamonti, L., Rodríguez, P. V., Bevan-Jones, W. R., O'Brien, J. T., et al. (2017) · Brain · doi:10.1093/brain/awx347 · Cited by 251
The neurobiologie consequences of down syndrome
Coyle, J. T., Oster-Granite, M. L., & Gearhart, J. D. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90074-2 · Cited by 248
Gajdusek, D. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121110 · Cited by 214
The nucleus basalis of Meynert in neurological disease: A quantitative morphological study
Rogers, J., BROGAN, D. R., & Mirra, S. S. (1985) · Annals of Neurology · doi:10.1002/ana.410170210 · Cited by 202
Creutzfeldt–Jakob Disease Prion Proteins in Human Brains
Bockman, J. M., Kingsbury, D. T., McKinley, M. P., Bendheim, P. E., & Prusiner, S. B. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501103120202 · Cited by 199
Self-citationPrions and Neurodegenerative Diseases
Epstein, F. H., & Prusiner, S. B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712173172505 · Cited by 192
Self-citationAmyloid plaques in Creutzfeldt‐Jakob disease stain with prion protein antibodies
Kitamoto, T., Tateishi, J., Tashima, T., Takeshita, I., Barry, R. A., DeArmond, S. J., & Prusiner, S. B. (1986) · Annals of Neurology · doi:10.1002/ana.410200205 · Cited by 178
Self-citationAxonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1
Brahic, M., Bousset, L., Bieri, G., Melki, R., & Gitler, A. D. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1538-0 · Cited by 169
Amyloid β-protein and beyond: the path forward in Alzheimer’s disease
Walsh, D. M., & Selkoe, D. J. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.02.003 · Cited by 164
Prion-Protein Immunoreactivity in Human Transmissible Dementias
Roberts, G. W., Lofthouse, R., Brown, R., Crow, T. J., Barry, R. A., & Prusiner, S. B. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611063151919 · Cited by 155
Self-citationBrown, P., Coker-Vann, M., Pomeroy, K. L., Franko, M. C., Asher, D. M., Gibbs, C. J., & Gajdusek, D. C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602273140904 · Cited by 154
Gajdusek, D. C. (1988) · Journal of Neuroimmunology · doi:10.1016/0165-5728(88)90140-3 · Cited by 151
Invited Review: The role of prion‐like mechanisms in neurodegenerative diseases
Jaunmuktane, Z., & Brandner, S. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12592 · Cited by 153
Widespread tau seeding activity at early Braak stages
Furman, J. L., Vaquer‐Alicea, J., White, C. L., Cairns, N. J., Nelson, P. T., & Diamond, M. I. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1644-z · Cited by 146
Vaquer‐Alicea, J., Diamond, M. I., & Joachimiak, Ł. A. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02301-7 · Cited by 139
Kascsak, R., Rubenstein, R., MERZ, P. A., Carp, R. I., Robakis, N. K. R. K., Wisniewski, H. M., & Diringer, H. (1986) · Journal of Virology · doi:10.1128/jvi.59.3.676-683.1986 · Cited by 140
β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View
Penke, B., Bogár, F., & Fülöp, L. (2017) · Molecules · doi:10.3390/molecules22101692 · Cited by 150
Brioni, J. D., Esbenshade, T. A., Garrison, T. R., Bitner, S. R., & Cowart, M. (2010) · Cited by 125
Identification of Candidate Proteins Binding to Prion Protein
Yehiely, F., Bamborough, P., Costa, M. D., Perry, B. J., Thinakaran, G., Cohen, F. E., Carlson, G. A., & Prusiner, S. B. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0130 · Cited by 121
Self-citationNussbaum, J. M., Seward, M. E., & Bloom, G. S. (2013) · Prion · doi:10.4161/pri.22118 · Cited by 128
Selkoe, D. J. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90055-2 · Cited by 116
It all sticks together—the APP-related family of proteins and Alzheimer's disease
Bayer, T. A., Cappai, R., Masters, C. L., Beyreuther, K. T., & Multhaup, G. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000552 · Cited by 121
Mapping Neurodegenerative Disease Onset and ProgressionPreprint
Seeley, W. W. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023622 · Cited by 109
Imaging plus X: multimodal models of neurodegenerative disease
Oxtoby, N. P., & Alexander, D. C. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000460 · Cited by 105
Ossenkoppele, R., Iaccarino, L., Schonhaut, D. R., Brown, J. A., Joie, R. L., O’Neil, J. P., Janabi, M., Baker, S. L., Kramer, J. H., Gorno‐Tempini, M., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101848 · Cited by 109
Data-driven modelling of neurodegenerative disease progression: thinking outside the black box
Young, A. L., Oxtoby, N. P., Garbarino, S., Fox, N. C., Barkhof, F., Schott, J. M., & Alexander, D. C. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00779-6 · Cited by 120
Tau forms oligomeric complexes on microtubules that are distinct from tau aggregates
Gyparaki, M. T., Arab, A., Sorokina, E. M., Santiago-Ruiz, A. N., Bohrer, C. H., Xiao, J., & Lakadamyali, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021461118 · Cited by 97
Chemical and Clinical Classification of Amyloidosis 1985
Husby, G., & Sletten, K. (1986) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1986.tb01966.x · Cited by 96
Amyloidosis of the nervous system
Glenner, G. G., & Murphy, M. A. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90214-1 · Cited by 93
Prions are novel infectious pathogens causing scrapie and creutzfeldt—Jakob disease
Prusiner, S. B. (1986) · BioEssays · doi:10.1002/bies.950050612 · Cited by 91
Self-citationAlzheimer’s disease and its treatment–yesterday, today, and tomorrow
Kim, A. Y., Jerdi, S. A., MacDonald, R., & Triggle, C. R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1399121 · Cited by 99
The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's DiseasePreprint
Walker, L. C., Schelle, J., & Jucker, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024398 · Cited by 95
Ammonia and Alzheimer’s disease
Seiler, N. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00041-4 · Cited by 88
Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease
Condello, C., & Stöhr, J. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.03.014 · Cited by 92
Clark, I. A., & Vissel, B. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13181 · Cited by 84
β-Amyloid Prions and the Pathobiology of Alzheimer’s DiseasePreprint
Watts, J. C., & Prusiner, S. B. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a023507 · Cited by 90
Self-citationThe Olfactory System and Alzheimer's Disease
Moyano, H. F., & Barragán, E. I. (1989) · International Journal of Neuroscience · doi:10.3109/00207458909084824 · Cited by 81
Immunoblotting of Creutzfeldt‐Jakob disease prion proteins: Host species—specific epitopes
Bockman, J. M., Prusiner, S. B., Tateishi, J., & Kingsbury, D. T. (1987) · Annals of Neurology · doi:10.1002/ana.410210611 · Cited by 80
Self-citationCellular mechanisms of protein aggregate propagation
Holmes, B. B., & Diamond, M. I. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a3ee0 · Cited by 80
Current directions in tau research: Highlights from Tau 2020
Sexton, C. E., Snyder, H. M., Beher, D., Boxer, A. L., Brannelly, P., Brion, J., Buée, L., Cacace, A. M., Chételat, G., Citron, M., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12452 · Cited by 89
Transmission of Scrapie in Hamsters
Prusiner, S. B., Cochran, S. P., & Alpers, M. P. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/152.5.971 · Cited by 79
Self-citationAnimal models of brain-first and body-first Parkinson's disease
Berge, N. V. D., & Ulusoy, A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105599 · Cited by 84
Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils
MERZ, P. A., Kascsak, R., Rubenstein, R., Carp, R. I., & Wisniewski, H. M. (1987) · Journal of Virology · doi:10.1128/jvi.61.1.42-49.1987 · Cited by 68
Prion-like mechanisms in Alzheimer disease
Walker, L. C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00016-7 · Cited by 67
Family caregivers: The experience of Alzheimer's disease
Wilson, H. S. (1989) · Applied Nursing Research · doi:10.1016/s0897-1897(89)80024-2 · Cited by 69
Prion-like features of misfolded Aβ and tau aggregates
Morales, R., Callegari, K., & Soto, C. A. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.031 · Cited by 65
Prions: Novel Infectious Pathogens
Prusiner, S. B. (1984) · Advances in virus research · doi:10.1016/s0065-3527(08)60404-2 · Cited by 62
Self-citationOn causative theories in Alzheimer's disease
Glenner, G. G. (1985) · Human Pathology · doi:10.1016/s0046-8177(85)80078-2 · Cited by 62
Cause and consequence of Aβ – Lipid interactions in Alzheimer disease pathogenesis
Rangachari, V., Dean, D. N., Rana, P., Vaidya, A., & Ghosh, P. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.03.004 · Cited by 61
Antemortem markers of Alzheimer's disease
Hollander, E., Mohs, R. C., & Davis, K. L. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90164-8 · Cited by 60
Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties
Tatarnikova, O. G., Орлов, М. А., & Bobkova, N. V. (2015) · Biochemistry (Moscow) · doi:10.1134/s000629791513012x · Cited by 62
PRIONS CAUSING DEGENERATIVE NEUROLOGICAL DISEASES
Prusiner, S. B. (1987) · Annual Review of Medicine · doi:10.1146/annurev.me.38.020187.002121 · Cited by 56
Self-citationElovaara, I., Maury, C. P. J., & Palo, J. (1986) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1986.tb07863.x · Cited by 52
Season of Birth in Alzheimer's Disease
Philpot, M. P., Rottenstein, M., Burns, A. S., & Der, G. (1989) · The British Journal of Psychiatry · doi:10.1192/s000712500001816x · Cited by 49
Amyloid-β pathology induced in humans
Jucker, M., & Walker, L. C. (2015) · Nature · doi:10.1038/525193a · Cited by 47
Alzheimer's Disease: Clinical Features, Pathogenesis, and Treatment
Rathmann, K. L., & Conner, C. S. (1984) · Annals of Pharmacotherapy · doi:10.1177/106002808401800902 · Cited by 48
Prusiner, S. B., Gabizon, R., & McKinley, M. P. (1987) · Acta Neuropathologica · doi:10.1007/bf00687261 · Cited by 46
Self-citationApplications of Resting-State Functional Connectivity to Neurodegenerative Disease
Zhou, J. H., Liu, S., Ng, K. K., & Wang, J. (2017) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2017.06.007 · Cited by 45
The Pathobiology Of Alzheimer's Disease
Glenner, G. G. (1989) · Annual Review of Medicine · doi:10.1146/annurev.me.40.020189.000401 · Cited by 43
Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer’s disease
Ounanian, A., Seigneurin, J. ‐., Guilbert, B., Avrameas, S., & Renverez, J. ‐. (1990) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860040510 · Cited by 58
Aβ Seeding as a Tool to Study Cerebral Amyloidosis and Associated Pathology
Friesen, M., & Meyer‐Luehmann, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00233 · Cited by 41
Is ammonia a pathogenetic factor in Alzheimer's disease?
Seiler, N. (1993) · Neurochemical Research · doi:10.1007/bf00969079 · Cited by 40
Alzheimer's Disease: Environmental Factors and Etiologic Hypotheses
Gautrin, D., & Gauthier, S. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029425 · Cited by 39
Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
Kaufman, S. K., & Diamond, M. I. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0196-3 · Cited by 40
Predictive Model of Spread of Progressive Supranuclear Palsy Using Directional Network Diffusion
Pandya, S., Mezias, C., & Raj, A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00692 · Cited by 39
Heterologous Aggregates Promote De Novo Prion Appearance via More than One Mechanism
Arslan, F., Hong, J. Y., Kanneganti, V., Park, S.-K., & Liebman, S. W. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004814 · Cited by 36
An Analysis of T Lymphocyte Subpopulations in Patients with Alzheimer's Disease
Leffell, M. S., Lumsden, L., & Steiger, W. A. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb02851.x · Cited by 36
Prion-like propagation of α-synuclein in neurodegenerative diseases
Tarutani, A., & Hasegawa, M. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.07.005 · Cited by 33
Prion-like properties of Tau assemblies
Clavaguera, F., Duyckaerts, C. J., & Haı̈k, S. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.022 · Cited by 32
Candy, J., Edwardson, J. A., Klinowski, J., Oakley, A. E., Perry, E. K., & Perry, R. H. (1985) · Advances in applied neurological sciences · doi:10.1007/978-3-642-70644-8_15 · Cited by 32
Aβ seeds and prions: How close the fit?
Rasmussen, J., Jucker, M., & Walker, L. C. (2017) · Prion · doi:10.1080/19336896.2017.1334029 · Cited by 33
“On–Off” Phenomenon in Parkinson’s Disease
Breitner, J. C., & Folstein, M. F. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407193110316 · Cited by 30
Aβ and tau prions feature in the neuropathogenesis of Down syndrome
Condello, C., Maxwell, A. M., Castillo, E., Aoyagi, A., Graff, C., Ingelsson, M., Lannfelt, L., Bird, T. D., Keene, C. D., Seeley, W. W., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212954119 · Cited by 27
Self-citationAlzheimer's Disease and Prion Protein
Zhou, J. (2013) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2013.v2.2.35 · Cited by 31
Molecular Structure, Biology, and Genetics of Prions
Prusiner, S. B. (1988) · Advances in virus research · doi:10.1016/s0065-3527(08)60709-5 · Cited by 27
Self-citationRecent research on the causes of Alzheimer's disease.
Deary, I. J., & Whalley, L. J. (1988) · BMJ · doi:10.1136/bmj.297.6652.807 · Cited by 26
Eraña, H., Venegas, V., Charco, J. M., & Castilla, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.166 · Cited by 26
Addition of exogenous SOD1 aggregates causes TDP-43 mislocalisation and aggregation
Zeineddine, R., Farrawell, N. E., Lambert-Smith, I. A., & Yerbury, J. J. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0804-y · Cited by 29
Perspectives on the Etiology of Alzheimer's Disease
Mozar, H. N. (1987) · JAMA · doi:10.1001/jama.1987.03390110079031 · Cited by 24
Maury, C. P. J., & Teppo, A. M. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90156-0 · Cited by 23
Metadata
- Authors
- Prusiner, S. B.
- Corresponding author
- Prusiner, Stanley B.
- ORCID
- Prusiner, Stanley B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1984-03-08
- Volume
- 310
- Issue
- 10
- Pages
- 661-663
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2014908349
- Cited by
- 213
- References
- 19
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 9 · 2023: 5 · 2022: 1 · 2021: 10 · 2020: 4 · 2019: 11 · 2018: 4 · 2017: 11 · 2016: 6 · 2015: 9 · 2014: 4 · 2013: 9 · 2012: 10
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- prions, amyloid, Alzheimer's disease, prion disease, Creutzfeldt-Jakob disease, kuru, Gerstmann-Sträussler-Scheinker disease, scrapie
- MeSH terms
- Aged, Alzheimer Disease, Amyloid, Animals, Brain, Humans, Creutzfeldt-Jakob Syndrome, Prions, Slow Virus Diseases, Viral Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
